Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aprea Therapeutics, Inc. | Director | Common Stock | 44.7K | $120K | $2.68 | Oct 11, 2024 | Direct |
Aptose Biosciences Inc. | Director | Common Shares | 17K | $24.6K | $1.45 | Sep 22, 2023 | Direct |
Aprea Therapeutics, Inc. | Director | Stock Options (Right to Buy) | 4.19K | Jun 20, 2024 | Direct | ||
Aprea Therapeutics, Inc. | Director | Tranche A Warrant | 3.43K | Mar 13, 2024 | Direct | ||
Aprea Therapeutics, Inc. | Director | Tranche B Warrant | 3.43K | Mar 13, 2024 | Direct | ||
Aptose Biosciences Inc. | Director | Director Stock Option (Right to Buy) | 3.33K | Feb 5, 2024 | Direct |